159 (PB039) - A combination vertical inhibition approach with inhibitors of SHP2 and ERK provides improved activity in KRAS-mutant pancreatic and colorectal cancer models
| Autor: | Hindley, C., Biondo, A., Brothwood, J., Dao, K.H., Kandola, N., Lyons, J., Nakatsuru, Y., Smyth, T., Wagner, S., Wallis, N., Hearn, K. |
|---|---|
| Zdroj: | In European Journal of Cancer October 2022 174 Supplement 1:S57-S57 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect